Prognostic indicators of KRAS G12X mutations in pancreatic cancer.

被引：0
|
作者：
Ardalan, Bach
Ciner, Aaron
Baca, Yasmine
Darabi, Sourat
Kasi, Anup
Lou, Emil
Azqueta, Jose Ignacio
Xiu, Joanne
Nabhan, Chadi
Shields, Anthony Frank
Pishvaian, Michael J.
Korn, Wolfgang Michael
Goel, Sanjay
机构：
[1] Univ Miami, Miami, FL USA
[2] Univ Maryland, Baltimore, MD 21201 USA
[3] Caris Life Sci, Phoenix, AZ USA
[4] Hoag Family Canc Inst, Newport Beach, CA USA
[5] Univ Kansas Med Ctr, Westwood, KS USA
[6] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA
[7] Univ Miami, Sylvester Canc Ctr, Miami, FL USA
[8] Barbara Ann Karmanos Canc Inst, Detroit, MI USA
[9] Johns Hopkins Univ, Sch Med, Washington, DC USA
[10] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
735
引用
收藏
页码：735 / 735
页数：1
相关论文
共 50 条
  • [41] Overcoming Cell Subtype-Specific Adaptive Resistance to KRAS G12D Inhibition in KRAS G12D-Mutant Pancreatic Cancer
    Lin, Qingxiang
    Morales, Alvin
    Barnes, Haley
    Corcoran, Ryan Bruce
    CANCER RESEARCH, 2024, 84 (17)
  • [42] Targeted nanodelivery of siRNA against KRAS G12D inhibits pancreatic cancer
    Huang, Ri
    Du, Hong
    Cheng, Liang
    Zhang, Peizhuo
    Meng, Fenghua
    Zhong, Zhiyuan
    ACTA BIOMATERIALIA, 2023, 168 : 529 - 539
  • [43] The prevalence and prognostic significance of KRAS G12C mutation in metastatic colorectal cancer
    Lutz, Joseph
    Khamis, Mohamed
    Alkharabsheh, Omar
    Sahin, Ibrahim Halil
    Khushman, Moh'd M.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 289 - 289
  • [44] Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies
    Linehan, Anna
    O'Reilly, Mary
    McDermott, Ray
    O'Kane, Grainne M.
    FRONTIERS IN MEDICINE, 2024, 11
  • [45] KRAS Mutations and Their Correlation With Survival of Patients With Advanced Pancreatic Cancer
    Bournet, Barbara
    Muscari, Fabrice
    Guimbaud, Rosine
    Cordelier, Pierre
    Buscail, Louis
    PANCREAS, 2013, 42 (03) : 543 - 544
  • [46] Prognostic value of BRAF and KRAS mutations in colorectal cancer patients
    Murata, Paola
    Stradella, Agostina
    Paez, David
    Tobena, Maria
    Sebio, Ana
    Pare, Laia
    Gonzalez, Alan
    Espinosa, Inigo
    Targarona, Eduardo
    Gich, Ignasi
    Barnadas, Agust
    Baiget, Montserrat
    Martin-Richard, Marta
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] PROGNOSTIC VALUE OF BRAF AND KRAS MUTATIONS IN COLORECTAL CANCER PATIENTS
    Murata, E. P.
    Stradella, A.
    Paez, D.
    Tobena Puyal, M.
    Sebio Garcia, A.
    Gonzalez, A.
    Targarona, E.
    Baiget, M.
    Barnadas, A.
    Martin-Richard, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 216 - 216
  • [48] Combination inhibitor strategies targeting KRAS effector signaling in KRAS-mutant pancreatic cancer.
    Ozkan-Dagliyan, Irem
    Goodwin, Craig M.
    Bryant, Kirsten L.
    George, Samuel D.
    Lucas, Kelly
    Gautam, Prson
    Wennerberg, Krister
    Cox, Adrienne D.
    Der, Channing J.
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 68 - 68
  • [49] Diagnostic and Prognostic Value of Circulating KRAS Mutations in Resectable Pancreatic Ductal Adenocarcinoma
    Hipp, J.
    Hussung, S.
    Duyster, J.
    Fichtner-Feigl, S.
    Fritsch, R.
    Wittel, U. A.
    PANCREAS, 2018, 47 (10) : 1392 - 1392
  • [50] G12V and G12C mutations in the gene KRAS are associated with a poorer prognosis in primary colorectal cancer
    Tamuro Hayama
    Yojiro Hashiguchi
    Koichi Okamoto
    Yuka Okada
    Kohei Ono
    Ryu Shimada
    Tsuyoshi Ozawa
    Tetsutaka Toyoda
    Takeshi Tsuchiya
    Hisae Iinuma
    Keijiro Nozawa
    Keiji Matsuda
    International Journal of Colorectal Disease, 2019, 34 : 1491 - 1496
12345